Generic Drugs

On June 3, 2009, the Energy and Commerce Subcommittee on Commerce, Trade, and Consumer Protection approved H.R. 1706, the “Protecting Consumer Access to Generic Drugs Act,” which would prohibit a brand name drug company from paying a generic drug company to stay off the market as part of a drug patent settlement. The Subcommittee passed the legislation on a 16-10 vote, sending it to the full Committee for further action. In a related development, the Senate Judiciary Committee has scheduled a June 11, 2009 markup of S.369, the "Preserve Access to Affordable Generics Act".

Trackbacks (1) Links to blogs that reference this article Trackback URL
http://www.healthindustrywashingtonwatch.com/admin/trackback/138112
Life Sciences Legal Update - June 9, 2009 10:10 AM
The Reed Smith Health Industry Washington Watch blog has been updated to discuss a variety of health policy developments, including the following: - FDA Transparency Task Force - Toll-Free Numbers for Adverse Events Reporting - Generic Drugs
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.